Previous reports have not clarified the specific molecular mechanism whereby PFD inhibits fibrosis, but most studies have concluded that TGF-β1 may be the key molecule in the action of PFD (Meng et al., 2016; Shinde et al., 2017). The gene discussed is TGFB1; the disease is polyostotic fibrous dysplasia.